Literature DB >> 33011046

Multidrug-Resistant Bacteria in the Community: An Update.

David van Duin1, David L Paterson2.   

Abstract

Multidrug-resistant bacteria are among the most important current threats to public health. Typically, they are associated with nosocomial infections. However, some have become prevalent causes of community-acquired infections, such as Neisseria gonorrhoeae, Shigella, Salmonella, and Streptococcus pneumoniae. The community spread of multidrug-resistant bacteria is also a crucial development. An important global threat on the horizon is represented by production of carbapenemases by community-acquired hypervirulent Klebsiella pneumoniae. Such strains have already been found in Asia, Europe, and North America. Prevention of further community spread of multidrug-resistant bacteria is of the utmost importance, and will require a multidisciplinary approach involving all stakeholders.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem resistant Enterobacteriaceae; Gonococcus; K pneumoniae; MRSA

Mesh:

Year:  2020        PMID: 33011046      PMCID: PMC8713071          DOI: 10.1016/j.idc.2020.08.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  86 in total

1.  Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China.

Authors:  C Peng; Z Zong; H Fan
Journal:  Clin Microbiol Infect       Date:  2012-10-11       Impact factor: 8.067

2.  Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections.

Authors:  Caitlin M Wolfe; Bevin Cohen; Elaine Larson
Journal:  J Infect Public Health       Date:  2014-03-13       Impact factor: 3.718

3.  Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan.

Authors:  Yen-Hua Huang; Sheng-Hua Chou; Syun-Wun Liang; Chung-En Ni; Yi-Tsung Lin; Yi-Wei Huang; Tsuey-Ching Yang
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

4.  A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.

Authors:  Danxia Gu; Ning Dong; Zhiwei Zheng; Di Lin; Man Huang; Lihua Wang; Edward Wai-Chi Chan; Lingbin Shu; Jiang Yu; Rong Zhang; Sheng Chen
Journal:  Lancet Infect Dis       Date:  2017-08-29       Impact factor: 25.071

5.  Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States.

Authors:  Pia S Pannaraj; Jennifer Dien Bard; Chiara Cerini; Scott J Weissman
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

6.  Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.

Authors:  Benjamin A Rogers; Paul R Ingram; Naomi Runnegar; Matthew C Pitman; Joshua T Freeman; Eugene Athan; Sally M Havers; Hanna E Sidjabat; Mark Jones; Earleen Gunning; Mary De Almeida; Kaylene Styles; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

7.  Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community.

Authors:  Ritu Banerjee; Jacob Strahilevitz; James R Johnson; Payal P Nagwekar; Donna M Schora; Ilene Shevrin; Hongyan Du; Lance R Peterson; Ari Robicsek
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-17       Impact factor: 3.254

8.  A treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria.

Authors:  Nachiket P Marathe; Viduthalai R Regina; Sandeep A Walujkar; Shakti Singh Charan; Edward R B Moore; D G Joakim Larsson; Yogesh S Shouche
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

9.  Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China.

Authors:  Rui Zheng; Qian Zhang; Yidan Guo; Yue Feng; Li Liu; Amei Zhang; Yue Zhao; Xiaoyu Yang; Xueshan Xia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-02-19       Impact factor: 3.944

Review 10.  Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects.

Authors:  T Coates; R Bax; A Coates
Journal:  J Antimicrob Chemother       Date:  2009-05-18       Impact factor: 5.790

View more
  12 in total

1.  Impact of Third-Generation Cephalosporin Resistance on Recurrence in Children with Febrile Urinary Tract Infections.

Authors:  Sin Young Kim; Min Sik Jang; Jihye Kim
Journal:  J Pers Med       Date:  2022-05-10

2.  Editorial: Antimicrobial Resistance as a Global Public Health Problem: How Can We Address It?

Authors:  Luciene Andrade Da Rocha Minarini; Leonardo Neves de Andrade; Eliana De Gregorio; Filipa Grosso; Thierry Naas; Raffaele Zarrilli; Ilana L B C Camargo
Journal:  Front Public Health       Date:  2020-11-12

3.  Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.

Authors:  Lewis F Neville; Itamar Shalit; Peter A Warn; Jacob T Rendell
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758

4.  mcr-1-Mediated In Vitro Inhibition of Plasmid Transfer Is Reversed by the Intestinal Environment.

Authors:  Xiaoman Yang; Rundong Shu; Leqi Hou; Panpan Ren; Xin Lu; Zhi Huang; Zengtao Zhong; Hui Wang
Journal:  Antibiotics (Basel)       Date:  2022-06-29

5.  Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy.

Authors:  Jiaoli Wang; Haoran Hu; Haixia Du; Man Luo; Yilan Cao; Jiaping Xu; Tianhang Chen; Yilei Guo; Qixiang Li; Wen Chen; Yifei Zhang; Jin Han; Haitong Wan
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

6.  Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways.

Authors:  Mallika Kumarihamy; Siddharth Tripathi; Premalatha Balachandran; Bharathi Avula; Jianping Zhao; Mei Wang; Maria M Bennett; Jin Zhang; Mary A Carr; K Michael Lovell; Ocean I Wellington; Mary E Marquart; N P Dhammika Nanayakkara; Ilias Muhammad
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

Review 7.  Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.

Authors:  Kathleen Tompkins; David van Duin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-06-24       Impact factor: 5.103

8.  Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution.

Authors:  Katerina Tsilipounidaki; Zoi Athanasakopoulou; Elke Müller; Sindy Burgold-Voigt; Zoi Florou; Sascha D Braun; Stefan Monecke; Nikolaos K Gatselis; Kalliopi Zachou; Aggelos Stefos; Ilias Tsagalas; Marina Sofia; Vassiliki Spyrou; Charalambos Billinis; George N Dalekos; Ralf Ehricht; Efthymia Petinaki
Journal:  Microorganisms       Date:  2022-01-13

Review 9.  Fungal Guttation, a Source of Bioactive Compounds, and Its Ecological Role-A Review.

Authors:  Adam Krain; Piotr Siupka
Journal:  Biomolecules       Date:  2021-08-25

Review 10.  Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"

Authors:  Khalil Chaïbi; Gauthier Péan de Ponfilly; Laurent Dortet; Jean-Ralph Zahar; Benoît Pilmis
Journal:  Antibiotics (Basel)       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.